Outcome of Board Meeting to held on 4th September, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Boston Bio Systems Limited's board approved multiple key items at its 4th September 2025 meeting. The statutory auditor M/s Nahar V & Company resigned due to pre-occupation with other assignments, and M/s Sunit M Chhatbar & Co. has been appointed to fill the casual vacancy, with their appointment also proposed for a 5-year term starting from the 30th AGM. The board approved significant alterations to the company's main object clause, adding new business areas including IT/software development, agriculture and farming, real estate development, and e-commerce/online commerce trading. A new set of Memorandum of Association (MOA) and Articles of Association (AOA) was approved to align with the Companies Act 2013. The board also approved the Board Report and Annual Report for FY ending 31st March 2025, the notice for the 30th AGM, and appointed a scrutinizer for the e-voting process.
The most material takeaway for shareholders is the dramatic diversification of business objects — moving beyond bio systems into IT, agriculture, real estate, and online commerce — which signals a major strategic pivot but remains subject to shareholder approval at the 30th AGM. The auditor change is routine and not flagged with any governance concerns.